This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v2.1.0: STU 2) based on FHIR R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
: cancer-related-medication-request-cisplatin - XML Representation
Raw xml | Download
<MedicationRequest xmlns="http://hl7.org/fhir">
<id value="cancer-related-medication-request-cisplatin"/>
<meta>
<profile
value="http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-request"/>
</meta>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: MedicationRequest</b><a name="cancer-related-medication-request-cisplatin"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource MedicationRequest "cancer-related-medication-request-cisplatin" </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-mcode-cancer-related-medication-request.html">Cancer-Related Medication Request Profile</a></p></div><p><b>Procedure Intent Extension</b>: Curative - procedure intent <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#373808002)</span></p><p><b>Treatment Termination Reason Extension</b>: Treatment completed (situation) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#182992009)</span></p><p><b>status</b>: active</p><p><b>intent</b>: order</p><p><b>medication</b>: CISplatin 50 MG per 50 ML Injectable Solution <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.0.0/CodeSystem-v3-rxNorm.html">RxNorm</a>#309311)</span></p><p><b>subject</b>: <a href="Patient-cancer-patient-john-anyperson.html">Patient/cancer-patient-john-anyperson</a> " ANYPERSON"</p><p><b>authoredOn</b>: 2019-04-01</p><p><b>requester</b>: <a href="Practitioner-us-core-practitioner-kyle-anydoc.html">Practitioner/us-core-practitioner-kyle-anydoc</a> " ANYDOC"</p><p><b>reasonCode</b>: Non-small cell lung cancer (disorder) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#254637007)</span></p><p><b>note</b>: Day 1 of NSCLC regimen: Cisplatin 75 mg/m2 day 1; docetaxel 75 mg/m2 day 1 every 21 days for 4 cycles.</p><blockquote><p><b>dosageInstruction</b></p><p><b>text</b>: calculate absolute dose on day of administration.</p><p><b>timing</b>: Events: 2019-06-15, Count 1 times, Once</p><p><b>route</b>: Intravenous use <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#47625008)</span></p><blockquote><p><b>doseAndRate</b></p></blockquote></blockquote></div>
</text>
<extension
url="http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-procedure-intent">
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="373808002"/>
<display value="Curative - procedure intent"/>
</coding>
</valueCodeableConcept>
</extension>
<extension
url="http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-treatment-termination-reason">
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="182992009"/>
<display value="Treatment completed (situation)"/>
</coding>
</valueCodeableConcept>
</extension>
<status value="active"/>
<intent value="order"/>
<medicationCodeableConcept>
<coding>
<system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
<code value="309311"/>
<display value="CISplatin 50 MG per 50 ML Injectable Solution"/>
</coding>
</medicationCodeableConcept>
<subject>
<reference value="Patient/cancer-patient-john-anyperson"/>
</subject>
<authoredOn value="2019-04-01"/>
<requester>
<reference value="Practitioner/us-core-practitioner-kyle-anydoc"/>
</requester>
<reasonCode>
<coding>
<system value="http://snomed.info/sct"/>
<code value="254637007"/>
<display value="Non-small cell lung cancer (disorder)"/>
</coding>
</reasonCode>
<note>
<text
value="Day 1 of NSCLC regimen: Cisplatin 75 mg/m2 day 1; docetaxel 75 mg/m2 day 1 every 21 days for 4 cycles."/>
</note>
<dosageInstruction>
<text value="calculate absolute dose on day of administration."/>
<timing>
<event value="2019-06-15"/>
<repeat>
<count value="1"/>
</repeat>
</timing>
<route>
<coding>
<system value="http://snomed.info/sct"/>
<code value="47625008"/>
<display value="Intravenous use"/>
</coding>
</route>
<doseAndRate>
<doseQuantity>
<value value="75"/>
<unit value="mg/m2"/>
<system value="http://unitsofmeasure.org"/>
<code value="mg/m2"/>
</doseQuantity>
</doseAndRate>
</dosageInstruction>
</MedicationRequest>